However, after sorafenib treatment, a dose-dependent decrease in colony number was observed in all six HCC cell lines; colonies of high-FGL1 expressing HCC cells were fewer than those of low-FGL1 expressing cells (Figure 2B). The gene discussed is FGL1; the disease is hepatocellular carcinoma.